Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial |
journalArticle |
2016 |
Ribrag, V.; Koscielny, S.; Bosq, J.; Leguay, T.; Casasnovas, O.; Fornecker, L. M.; Recher, C.; Ghesquieres, H.; Morschhauser, F.; Girault, S.; Le Gouill, S.; Ojeda-Uribe, M.; Mariette, C.; Cornillon, J.; Cartron, G.; Verge, V.; Chassagne-Clement, C.; Dombret, H.; Coiffier, B.; Lamy, T.; Tilly, H.; Salles, G. |
Impact of primary para-aortic lymphadenectomy on distant failure in locally advanced cervical cancer patients treated in the era of image-guided adaptive brachytherapy |
journalArticle |
2016 |
Chargari, C.; Mazeron, R.; Dunant, A.; Gouy, S.; Petit, C.; Maroun, P.; Uzan, C.; Annede, P.; Bentivegna, E.; Balleyguier, C.; Genestie, C.; Pautier, P.; Leary, A.; Lhomme, C.; Deutsch, E.; Morice, P.; Haie-Meder, C. |
French Intensive Care Society, International congress - Reanimation 2016 |
journalArticle |
2016 |
Jaillette, E.; Girault, C.; Brunin, G.; Zerimech, F.; Chiche, A.; Broucqsault-Dedrie, C.; al |
The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report |
journalArticle |
2016 |
Kager, L.; Whelan, J.; Dirksen, U.; Hassan, B.; Anninga, J.; Bennister, L.; Bovee, Jvmg; Brennan, B.; Broto, J. M.; Brugieres, L.; Cleton-Jansen, A. M.; Copland, C.; Dutour, A.; Fagioli, F.; Ferrari, S.; Fiocco, M.; Fleuren, E.; Gaspar, N.; Gelderblom, H.; Gerrand, C.; Gerss, J.; Gonzato, O.; van der Graaf, W.; Hecker-Nolting, S.; Herrero-Martin, D.; Klco-Brosius, S.; Kovar, H.; Ladenstein, R.; Lancia, C.; LeDeley, M. C.; McCabe, M. G.; Metzler, M.; Myklebost, O.; Nathrath, M.; Picci, P.; Potratz, J.; Redini, F.; Richter, G. H. S.; Reinke, D.; Rutkowski, P.; Scotlandi, K.; Strauss, S.; Thomas, D.; Tirado, O. M.; Tirode, F.; Vassal, G.; Bielack, S. S. |
Prognostic value of the infarct- and non-infarct like patterns and cardiovascular magnetic resonance parameters on long-term outcome of patients after acute myocarditis |
journalArticle |
2016 |
Chopra, H.; Arangalage, D.; Bouleti, C.; Zarka, S.; Fayard, F.; Chillon, S.; Laissy, J. P.; Henry-Feugeas, M. C.; Steg, P. G.; Vahanian, A.; Ou, P. |
Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab |
journalArticle |
2016 |
Lassau, N.; Coiffier, B.; Kind, M.; Vilgrain, V.; Lacroix, J.; Cuinet, M.; Taieb, S.; Aziza, R.; Sarran, A.; Labbe-Devilliers, C.; Gallix, B.; Lucidarme, O.; Ptak, Y.; Rocher, L.; Caquot, L. M.; Chagnon, S.; Marion, D.; Luciani, A.; Feutray, S.; Uzan-Augui, J.; Benatsou, B.; Bonastre, J.; Koscielny, S. |
Challenges of phase 1 clinical trials evaluating immune checkpoint-targeted antibodies |
journalArticle |
2016 |
Postel-Vinay, S.; Aspeslagh, S.; Lanoy, E.; Robert, C.; Soria, J. C.; Marabelle, A. |
Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials |
journalArticle |
2016 |
Le Tourneau, C.; Kamal, M.; Tsimberidou, A. M.; Bedard, P.; Pierron, G.; Callens, C.; Rouleau, E.; Vincent-Salomon, A.; Servant, N.; Alt, M.; Rouzier, R.; Paoletti, X.; Delattre, O.; Bieche, I. |
Standardized evaluation of tumor-infiltrating lymphocytes in breast cancer: results of the ring studies of the international immuno-oncology biomarker working group |
journalArticle |
2016 |
Denkert, C.; Wienert, S.; Poterie, A.; Loibl, S.; Budczies, J.; Badve, S.; Bago-Horvath, Z.; Bane, A.; Bedri, S.; Brock, J.; Chmielik, E.; Christgen, M.; Colpaert, C.; Demaria, S.; Van den Eynden, G.; Floris, G.; Fox, S. B.; Gao, D.; Ingold Heppner, B.; Kim, S. R.; Kos, Z.; Kreipe, H. H.; Lakhani, S. R.; Penault-Llorca, F.; Pruneri, G.; Radosevic-Robin, N.; Rimm, D. L.; Schnitt, S. J.; Sinn, B. V.; Sinn, P.; Sirtaine, N.; O'Toole, S. A.; Viale, G.; Van de Vijver, K.; de Wind, R.; von Minckwitz, G.; Klauschen, F.; Untch, M.; Fasching, P. A.; Reimer, T.; Willard-Gallo, K.; Michiels, S.; Loi, S.; Salgado, R. |
Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study |
journalArticle |
2016 |
Lueza, B.; Mauguen, A.; Pignon, J. P.; Rivero-Arias, O.; Bonastre, J.; Group, Mar-Lc Collaborative |
Uncovering Professional Attitudes Toward Treatment of Rare Carcinomas of the Breast: An International Practice e-Survey Involving 32 Countries |
journalArticle |
2016 |
Saghatchian, M.; Fadoukhair, Z.; Hofert, K.; Lanoy, E.; Mathieu, M. C.; Mazouni, C.; Delaloge, S. |
Treatment strategies in early-stage oropharyngeal squamous cell carcinoma: a French national survey |
journalArticle |
2016 |
Gorphe, P.; Blanchard, P.; Moriniere, S.; Fakhry, N. |
MRI-guided brachytherapy in locally advanced cervical cancer: Small bowel [Formula: see text] and [Formula: see text] are not predictive of late morbidity |
journalArticle |
2016 |
Petit, C.; Dumas, I.; Chargari, C.; Martinetti, F.; Maroun, P.; Doyeux, K.; Tailleur, A.; Haie-Meder, C.; Mazeron, R. |
Impact of dermatologic adverse events induced by targeted therapies on quality of life |
journalArticle |
2016 |
Charles, C.; Bungener, C.; Razavi, D.; Mateus, C.; Routier, E.; Lanoy, E.; Verschoore, M.; Robert, C.; Dauchy, S. |
Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents |
journalArticle |
2016 |
Merlevede, J.; Droin, N.; Qin, T.; Meldi, K.; Yoshida, K.; Morabito, M.; Chautard, E.; Auboeuf, D.; Fenaux, P.; Braun, T.; Itzykson, R.; de Botton, S.; Quesnel, B.; Commes, T.; Jourdan, E.; Vainchenker, W.; Bernard, O.; Pata-Merci, N.; Solier, S.; Gayevskiy, V.; Dinger, M. E.; Cowley, M. J.; Selimoglu-Buet, D.; Meyer, V.; Artiguenave, F.; Deleuze, J. F.; Preudhomme, C.; Stratton, M. R.; Alexandrov, L. B.; Padron, E.; Ogawa, S.; Koscielny, S.; Figueroa, M.; Solary, E. |
Empirical extensions of the lasso penalty to reduce the false discovery rate in high-dimensional Cox regression models |
journalArticle |
2016 |
Ternes, N.; Rotolo, F.; Michiels, S. |
[Oral cavity cancers among young people: Clinical results and prognostic analysis] |
journalArticle |
2016 |
Blanchard, P.; El Khoury, C.; Temam, S.; Casiraghi, O.; Mirghani, H.; Levy, A.; Gorphe, P.; Even, C.; De Felice, F.; Nguyen, F.; Janot, F.; Tao, Y. |
Underuse of self-controlled designs in pharmacoepidemiology in electronic healthcare databases: a systematic review |
journalArticle |
2016 |
Gault, N.; Castaneda-Sanabria, J.; Guillo, S.; Foulon, S.; Tubach, F. |
Combining multi-criteria decision analysis and mini-health technology assessment: A funding decision-support tool for medical devices in a university hospital setting |
journalArticle |
2016 |
Martelli, N.; Hansen, P.; van den Brink, H.; Boudard, A.; Cordonnier, A. L.; Devaux, C.; Pineau, J.; Prognon, P.; Borget, I. |
Assessing head and neck cancer patient preferences and expectations: A systematic review |
journalArticle |
2016 |
Blanchard, P.; Volk, R. J.; Ringash, J.; Peterson, S. K.; Hutcheson, K. A.; Frank, S. J. |
[Clinical burden caused by hospitalization for febrile neutropenia in France in 2010-2011: An analysis of the PMSI database] |
journalArticle |
2016 |
Freyer, G.; Scotte, F.; Borget, I.; Bruyas, A.; Vainchtock, A.; Chouaid, C. |
Treatment of squamous cell carcinoma of the posterior pharyngeal wall: Radiotherapy versus surgery |
journalArticle |
2016 |
De Felice, F.; Blanchard, P.; Levy, A.; Nguyen, F.; Gorphe, P.; Janot, F.; Temam, S.; Tao, Y. |
European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer |
journalArticle |
2016 |
Marguet, S.; Mazouni, C.; Ramaekers, B. L.; Dunant, A.; Kates, R.; Jacobs, V. R.; Joore, M. A.; Harbeck, N.; Bonastre, J. |
Results and Survival of Locally Advanced AJCC 7th Edition T4a Laryngeal Squamous Cell Carcinoma Treated with Primary Total Laryngectomy and Postoperative Radiotherapy |
journalArticle |
2016 |
Gorphe, P.; Matias, M.; Moya-Plana, A.; Tabarino, F.; Blanchard, P.; Tao, Y.; Janot, F.; Temam, S. |
Phenotypic and genetic heterogeneity of tumor tissue and circulating tumor cells in patients with metastatic castration-resistant prostate cancer: A report from the PETRUS prospective study |
journalArticle |
2016 |
Massard, C.; Oulhen, M.; Le Moulec, S.; Auger, N.; Foulon, S.; Abou-Lovergne, A.; Billiot, F.; Valent, A.; Marty, V.; Loriot, Y.; Fizazi, K.; Vielh, P.; Farace, F. |
Outcome of and prognostic factors for relapse in children and adolescents with mature B-cell lymphoma and leukemia treated in three consecutive prospective "Lymphomes Malins B" protocols. A Société Française des Cancers de l'Enfant study |
journalArticle |
2015 |
Jourdain, A.; Auperin, A.; Minard-Colin, V.; Aladjidi, N.; Zsiros, J.; Coze, C.; Gandemer, V.; Bertrand, Y.; Leverger, G.; Bergeron, C.; Michon, J.; Patte, C. |
Influence of the vocal cord mobility in salvage surgery after radiotherapy for early-stage squamous cell carcinoma of the glottic larynx |
journalArticle |
2015 |
Gorphe, P.; Blanchard, P.; Temam, S.; Janot, F. |
Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial |
journalArticle |
2015 |
Borget, I.; Bonastre, J.; Catargi, B.; Déandréis, D.; Zerdoud, S.; Rusu, D.; Bardet, S.; Leenhardt, L.; Bastie, D.; Schvartz, C.; Vera, P.; Morel, O.; Benisvy, D.; Bournaud, C.; Bonichon, F.; Kelly, A.; Toubert, M. E.; Leboulleux, S.; Journeau, F.; Benhamou, E.; Schlumberger, M. |
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma |
journalArticle |
2015 |
Hadoux, J.; Malka, D.; Planchard, D.; Scoazec, J. Y.; Caramella, C.; Guigay, J.; Boige, V.; Leboulleux, S.; Burtin, P.; Berdelou, A.; Loriot, Y.; Duvillard, P.; Chougnet, C. N.; Déandréis, D.; Schlumberger, M.; Borget, I.; Ducreux, M.; Baudin, E. |
Statistical controversies in clinical research: requiem for the 3 + 3 design for phase I trials |
journalArticle |
2015 |
Paoletti, X.; Ezzalfani, M.; Le Tourneau, C. |
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials |
journalArticle |
2015 |
Coleman, R.; Powles, T.; Paterson, A.; Gnant, M.; Anderson, S.; Diel, I.; Gralow, J.; von Minckwitz, G.; Moebus, V.; Bergh, J.; Pritchard, K. I.; Bliss, J.; Cameron, D.; Evans, V.; Pan, H.; Peto, R.; Bradley, R.; Gray, R. |
Locoregional symptoms in patients with de novo metastatic prostate cancer: Morbidity, management, and disease outcome |
journalArticle |
2015 |
Patrikidou, A.; Brureau, L.; Casenave, J.; Albiges, L.; Di Palma, M.; Patard, J. J.; Baumert, H.; Blanchard, P.; Bossi, A.; Kitikidou, K.; Massard, C.; Fizazi, K.; Blanchet, P.; Loriot, Y. |
Post-first-line FOLFOX chemotherapy for grade 3 neuroendocrine carcinoma |
journalArticle |
2015 |
Hadoux, J.; Malka, D.; Planchard, D.; Scoazec, J. Y.; Caramella, C.; Guigay, J.; Boige, V.; Leboulleux, S.; Burtin, P.; Berdelou, A.; Loriot, Y.; Duvillard, P.; Chougnet, C. N.; Déandréis, D.; Schlumberger, M.; Borget, I.; Ducreux, M.; Baudin, E. |
Mortality from Circulatory System Diseases among French Uranium Miners: A Nested Case-Control Study |
journalArticle |
2015 |
Drubay, D.; Caer-Lorho, S.; Laroche, P.; Laurier, D.; Rage, E. |
Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor |
journalArticle |
2015 |
Joskin, J.; de Baere, T.; Auperin, A.; Tselikas, L.; Guiu, B.; Farouil, G.; Boige, V.; Malka, D.; Leboulleux, S.; Ducreux, M.; Baudin, E.; Deschamps, F. |
A 16-gene assay to predict recurrence after surgery in localised renal cell carcinoma: development and validation studies |
journalArticle |
2015 |
Rini, B.; Goddard, A.; Knezevic, D.; Maddala, T.; Zhou, M.; Aydin, H.; Campbell, S.; Elson, P.; Koscielny, S.; Lopatin, M.; Svedman, C.; Martini, J. F.; Williams, J. A.; Verkarre, V.; Radulescu, C.; Neuzillet, Y.; Hemmerle, I.; Timsit, M. O.; Tsiatis, A. C.; Bonham, M.; Lebret, T.; Mejean, A.; Escudier, B. |
Precision medicine for metastatic breast cancer--limitations and solutions |
journalArticle |
2015 |
Arnedos, M.; Vicier, C.; Loi, S.; Lefebvre, C.; Michiels, S.; Bonnefoi, H.; Andre, F. |
Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial |
journalArticle |
2015 |
Levy, A.; Azria, D.; Pignon, J. P.; Delarochefordiere, A.; Martel-Lafay, I.; Rio, E.; Malka, D.; Conroy, T.; Miglianico, L.; Becouarn, Y.; Malekzadeh, K.; Leclercq, J.; Juzyna, B.; Ezra, P.; Lemanski, C.; Deutsch, E. |
Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma |
journalArticle |
2015 |
Diouf, M.; Bonnetain, F.; Barbare, J. C.; Bouche, O.; Dahan, L.; Paoletti, X.; Filleron, T. |
Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement |
journalArticle |
2015 |
Stewart, L. A.; Clarke, M.; Rovers, M.; Riley, R. D.; Simmonds, M.; Stewart, G.; Tierney, J. F.; Group, Prisma-Ipd Development |